VESPA Trial: Endovenous laser treatment versus crossectomy of the small saphenous vein.

VESPA Trial: Endovenous laser treatment versus crossectomy of the small saphenous vein. - VESPA

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON32315

Enrollment

180

Registered

2008-07-24

Start date

2008-11-01

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

varicose veins venous insufficiency

Interventions

Ligation of saphenopopliteal junction versus EVLT.

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Insufficiency of the saphenopopliteal junction.

Exclusion criteria

Exclusion criteria: Diameter of the small saphenous vein less than 2 mm. Occlusion of the deep venous system tortuous small saphenous vein

Design outcomes

Primary

Measure	Time frame
Insufficiency after 6 weeks (therapyfailure). Insufficiency after 1 year (recurrence)	—

Secondary

Measure	Time frame
Quality of life, morbidity, cosmetic results, duration of treatment, resumption of work.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)